|Grant, 7/10 ||€10.7M|
|Series C, 7/10 |
French Strategic Investment Funds
|Series C, 10/10 |
IXO Private Equity
Cerenis Therapeutics is a multinational biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases.